Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-02 @ 10:05 AM
Study NCT ID:
NCT02206503
Status:
COMPLETED
Last Update Posted:
2018-08-02
First Post:
2014-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
Sponsor:
Fondazione EMN Italy Onlus
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-06
First Submit QC Date:
None
Study First Post Date:
2014-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-01
Last Update Post Date:
2018-08-02
Last Update Post Date Type:
ACTUAL